Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors
US10059923B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2009 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Sep 13, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1394
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The inventive subject matter relates to methods for treating a T-cell deficiency in a subject in need thereof, comprising administering to said subject a T-cell precursor isolated from an allogeneic donor, provided that said allogeneic donor is not MHC-matched to said subject. The inventive methods can be further enhanced by genetic engineering for targeted immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.